Analyst Ratings for Jazz Pharmaceuticals PLC (JAZZ)

Updated: 2017-07-27

Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) have received a consensus rating of Buy from Wall Street analysts. Last month, JAZZ received an average rating of Buy.

A buy rating was issued by 15 analysts, 0 gave an overweight rating, 3 gave a hold rating, 0 gave an underweight rating, and 0 gave a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Many analysts weighed in on price targets for JAZZ. The most optimistic analyst gave a price target of 210, implying potential capital gains of 32.38 percent. The lowest price target was 144, implying a possible loss of -9.23 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is -4.87 percent. Meanwhile, fiscal year estimates have been revised upwards by 0.05 percent, compared to last month. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -2.47 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 0 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts made negative revisions. Over the same time period, 0 analysts revised their FY earnings estimates upwards, while 0 analysts made negative revisions to their fiscal year's estimates.

The growth rate of JAZZ's earnings is estimated by analysts to be 9.61 percent. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, because people typically see that as an indicator of higher growth relative to stock price. People often look for the PEG ratio to be under 1, though it could be better to see where the ratio stands relative to peers in the industry. JAZZ has a PEG ratio of 2.53.

JAZZ has traded between a high of 163.75 and a low of 95.80 over the past year. The current market price is above the trailing year's low by 65.59 percent, and below the high by 3.12 percent. JAZZ has a P/E ratio of 24.29. Investors typically compare the P/E ratio to a company's peers in the industry. The JAZZ value stock report compares JAZZ to some of its peers using value stock charts. The market cap of JAZZ is $9.71 billion. JAZZ's next earnings release will be on 0000-00-00, which is days away.